Loading...
Market
Lead Entity for Equity Financing in Transcarent's Acquisition of Accolade?
2
Resolution / Starting Odds
General Catalyst • 25%
62 Ventures • 25%
Another entity • 25%
Joint leadership • 25%
Official press releases from Transcarent or financial news outlets.
Story
Transcarent to Acquire Accolade for $621 Million at $7.03 Per Share, Serving 1,400 Clients
Jan 8, 2025, 02:32 PM
Transcarent, a healthcare navigation company, has announced plans to acquire Accolade, a health benefits platform, for $621 million. The deal, which values Accolade at $7.03 per share, represents a 110% premium over its closing stock price on the previous trading day. The transaction will be financed through an equity financing led by General Catalyst and 62 Ventures, with the deal expected to close in the second quarter of 2025. Upon completion, Accolade will become a privately held company and its common stock will no longer be listed on Nasdaq. The combined company aims to serve over 1,400 employer and payer clients, enhancing Transcarent's mission to provide high-quality, affordable health and care by integrating its generative AI-powered WayFinding and care experiences with Accolade's advocacy, expert medical opinions, and primary care services.
View original story
Similar markets
2PointZero • 25%
Stellantis • 25%
United Airlines • 25%
Wellington Management • 25%
Galaxy Ventures • 25%
Lightspeed Faction • 25%
Brevan Howard Digital • 25%
Haun Ventures • 25%
Lightspeed Venture Partners • 25%
Other • 25%
Another major VC firm • 25%
Amazon • 25%
Private equity firms • 25%
Other • 25%
Public market investors • 25%
Venture capital firms • 25%
Other • 25%
Galaxy Digital • 25%
Dragonfly Capital • 25%
ParaFi Capital • 25%
Lightspeed Venture Partners • 25%
Other • 25%
Another major VC firm • 25%
A new investor • 25%
Another existing investor • 25%
Amazon • 25%
Scale AI • 25%
Saronic • 25%
SpaceX • 25%
OpenAI • 25%
Samsung Securities • 25%
AFW Partners • 25%
Jeff Bezos • 25%
Other • 25%
Other • 25%
Dollar Tree • 25%
Walmart • 25%
Amazon • 25%
Silver Lake Partners • 25%
Other • 25%
Arctos Partners • 25%
Ares Management • 25%
Venture Capital Firm • 25%
Other • 25%
Private Equity Firm • 25%
Sovereign Wealth Fund • 25%
